BHBruno Hoen

Bruno Hoen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bruno Hoen has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Infective Endocarditis

    by Bruno Hoen, Xavier Duval

    In their review on infective endocarditis, Hoen and Duval (April 11 issue)1 advocate that when valve replacement is performed during antibiotic treatment for native-valve infective endocarditis, antimicrobial therapy should not be switched to that recommended for prosthetic-valve infective endocarditis. Although supported by few data, such a strategy is in line with the 2009 European Society of Cardiology guidelines.2 However, to our knowledge, only one retrospective study conducted at a single center with a small sample is available on the topic, and it showed cure rates that were similar regardless of the antimicrobial regimen administered.3 By contrast, the 2005 American Heart Association guidelines recommend that for patients with native-valve infective endocarditis who undergo valve replacement with a prosthetic valve, the postoperative treatment regimen should be the one recommended for the treatment of prosthetic-valve infective endocarditis rather than the one recommended for the treatment of native-valve infective endocarditis.4 Thus, regarding valve replacement performed during antibiotic treatment of native-valve infective endocarditis, there is still debate about whether to switch antimicrobial therapy to the treatment recommended for prosthetic-valve infective endocarditis. Further studies are needed to address this critical issue.


  • Open Access

    An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy

    by P Pugliese, C Delpierre, L Cuzin, I Poizot‐Martin, D Rey, K Saune, J Cottalorda, D Bettinger, C Delaugerre, B Hoen, et al.

    Objectives: The aim of the study was to assess whether patients with undetectable viraemia [a negative polymerase chain reaction result (PCRneg)] and those with plasma viral load (PVL) < 40 HIV‐1 RNA copies/mL but a detectable (positive) PCR signal (PCRpos) had different outcomes in terms of the development of blips and virological failure (VF).Methods: A multicentre observational database analysis was carried out. Data for patients whose highly active antiretroviral therapy (HAART) regime had been unchanged for ≥ 6 months by 1 January 2008, whose first two PVL measurements of 2008 were < 40 copies/mL and who had at least five PVL measurements between 1 January 2008 and 31 December 2010 were extracted from a multicentre observational database of 4928 patients receiving HAART. PVL assays used during this period had a detection threshold of 20 or 40 copies/mL. Undetectable PVL at baseline (BLPCRneg) was defined as PCRneg at the first two PVL determinations of 2008. Multivariable Cox regression analysis was performed to investigate factors associated with the occurrence of blips and VF, defined as two consecutive PVL measurements > 40 copies/mL.Results: Of the 1957 patients included in the study (mean age 47 years; median antiretroviral exposure 10.3 years), 1312 had BLPCRneg. Outcome events included 322 blips and 139 VFs, with incidence rates being significantly lower in patients with BLPCRneg than in those with BLPCRpos [13.0% vs. 23.4% (P < 0.0001) and 5.1% vs. 11.2% (P < 0.0001), respectively]. In multivariable analysis, BLPCRneg was associated with a reduced risk of blips [hazard ratio (HR) 0.58; 95% confidence interval (CI) 0.47–0.73; P < 0.0001] and VF (HR 0.44; 95% CI 0.31–0.62; P < 0.0001).Conclusions: Patients with PCRneg had better virological outcomes than those with PVL < 40 copies/mL but detectable viraemia. This suggests that the ‘no‐signal’ information provided by currently commercially available HIV RNA quantification assays should be used routinely.


  • Top Cited Papers

    Infective Endocarditis

    by Bruno Hoen, Xavier Duval

    Diagnosis of endocarditis is usually based on clinical, microbiologic, and echocardiographic findings. Treatment involves antimicrobial therapy targeted to the identified organism. Surgical indications include heart failure, uncontrolled infection, and prevention of embolic events.


  • Open Access

    Neisseria siccaEndocarditis Complicated by Intracranial and Popliteal Aneurysms in a Patient with a Bicuspid Aortic Valve

    by Guillaume Debellemanière, Catherine Chirouze, Laurent Hustache-Mathieu, Damien Fournier, Alessandra Biondi, Bruno Hoen

    We report a case of infective endocarditis due toNeisseria siccacomplicated by intracranial and popliteal aneurysms and hepatic and splenic infarcts in a patient with a bicuspid aortic valve. No predisposing factor other than poor dental condition was found. The patient fully recovered after antibiotic therapy, aortic and mitral valve replacement, endovascular occlusion of the middle-cerebral artery aneurysm, and surgical treatment of the popliteal artery aneurysm.


  • Top Cited Papers
    Open Access

    Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey

    by Christine Selton-Suty, Marie Célard, Vincent Le Moing, Thanh Doco-Lecompte, Catherine Chirouze, Bernard Iung, Christophe Strady, Matthieu Revest, François Vandenesch, Anne Bouvet, et al.

    Background. Observational studies showed that the profile of infective endocarditis (IE) significantly changed over the past decades. However, most studies involved referral centers. We conducted a population-based study to control for this referral bias. The objective was to update the description of characteristics of IE in France and to compare the profile of community-acquired versus healthcare-associated IE. Methods. A prospective population-based observational study conducted in all medical facilities from 7 French regions (32% of French individuals aged ≥18 years) identified 497 adults with Duke-Li–definite IE who were first admitted to the hospital in 2008. Main measures included age-standardized and sex-standardized incidence of IE and multivariate Cox regression analysis for risk factors of in-hospital death. Results. The age-standardized and sex-standardized annual incidence of IE was 33.8 (95% confidence interval [CI], 30.8–36.9) cases per million inhabitants. The incidence was highest in men aged 75–79 years. A majority of patients had no previously known heart disease. Staphylococci were the most common causal agents, accounting for 36.2% of cases (Staphylococcus aureus, 26.6%; coagulase-negative staphylococci, 9.7%). Healthcare-associated IE represented 26.7% of all cases and exhibited a clinical pattern significantly different from that of community-acquired IE. S. aureus as the causal agent of IE was the most important factor associated with in-hospital death in community-acquired IE (hazard ratio [HR], 2.82 [95% CI, 1.72–4.61]) and the single factor in healthcare-associated IE (HR, 2.54 [95% CI, 1.33–4.85]). Conclusions. S. aureus became both the leading cause and the most important prognostic factor of IE, and healthcare-associated IE appeared as a major subgroup of the disease.


    • 1 April 2012
      • Vol. 62  (4) , 511-4

    [Epidemiology of infective endocarditis].

    by Bruno Hoen, Xavier Duval

    In industrialized countries, after the eradication of rheumatic fever, rheumatic valve diseases progressively disappeared and the proportion of post-rheumatic infective endocarditis significantly decreased. Intravenous drug use, prosthetic valves, age-related degenerative valve sclerosis, and invasive procedures have become the most important risk factors for infective endocarditis. These changes resulted in a decreased incidence of streptococcal endocarditis and an increased incidence of staphylococcal endocarditis.


  • 190 Surgery of infective endocarditis analyzed within a one-year population-based study

    by François Delahaye, Christine Suty-Selton, Bernard Iung, Jean-François Obadia, Vincent Le Moing, Jean-Marc Frapier, Sidney Chocron, François Alla, Xavier Duval, Bruno Hoen